PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2013 | 63 |
| 2014 | 104 |
| 2015 | 72 |
| 2016 | 86 |
| 2017 | 71 |
| 2018 | 67 |
| 2019 | 53 |
| 2020 | 107 |
| 2021 | 141 |
| 2022 | 104 |
| 2023 | 85 |
| 2024 | 117 |
| 2025 | 107 |
| 2026 | 42 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"endocrinol metab seoul"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Nationwide Survey of Korean Endocrinologists on Barriers to Implementing Smart Healthcare Technologies.
- Baek HS, Kim MK, Kwon SY, Kim K, Park SS, Moon JH, Choi YM, Cho JH; Smart Healthcare Committee of the Korean Endocrine Society.
- Endocrinol Metab (Seoul). 2026 Aug 31;41(4):579-585. doi: 10.3803/EnM.2026.3264.
- PMCID: PMC13555218
Baek HS, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555218 -
Postoperative Surveillance in Differentiated Thyroid Cancer: Response-Adapted De-Escalation in the 2025 American Thyroid Association and 2026 Korean Thyroid Association Guidelines.
- Cho SW.
- Endocrinol Metab (Seoul). 2026 Aug 31;41(4):535-538. doi: 10.3803/EnM.2026.3156.
- PMCID: PMC13555219
Cho SW.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555219 -
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026.
- Lee EK, Kang SH, Koo BS, Kim M, Kim MJ, Kim BH, Kim JW, Na DG, Park S, Bang JI, Back K, Seo Y, Son YI, Song YS, Shin DY, Ahn JH, Ahn HY, Oh SW, Won HR, Yoo WS, Lee MK, Lee SW, Lee J, Lee JY, Lim DJ, Chung KW, Chong A, Jung JH, Cho SW, Cho YY, Hong CM, Park YJ; Korean Thyroid Association Guideline Committee on the Management of Thyroid Nodule and Cancer.
- Endocrinol Metab (Seoul). 2026 Aug 31;41(4):493-534. doi: 10.3803/EnM.2026.3149.
- PMCID: PMC13555224
Lee EK, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555224 -
Hypothalamus-Peripheral Organ Crosstalk in Energy Metabolism: A Bidirectional Regulatory Network.
- Hong Y, Shin S, Cho SK, Kim KW.
- Endocrinol Metab (Seoul). 2026 Aug 19;41(4):473-492. doi: 10.3803/EnM.2026.3077.
- PMCID: PMC13555225
Hong Y, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555225 -
Hypercortisolism in Type 2 Diabetes with Treatment-Resistant Hyperglycemia: A Treatable Metabolic Phenotype?
- Bae JC.
- Endocrinol Metab (Seoul). 2026 Aug 12;41(4):539-542. doi: 10.3803/EnM.2026.3196.
- PMCID: PMC13555220
Bae JC.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555220 -
Clinical Characteristics and Outcomes of Korean Patients with Lipoid Congenital Adrenal Hyperplasia: An Analysis of Data from the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) Cohort Study.
- Lee Y, Kim M, Lee YJ, Cho SY, Suh J, Ahn MB, Cheon CK, Kim CJ, Lim HH, Chung S, Cho WK, Yoo EG, Shin CH, Yoo HW, Lee YA.
- Endocrinol Metab (Seoul). 2026 May 26;41(4):566-578. doi: 10.3803/EnM.2025.2611.
- PMCID: PMC13555223
Lee Y, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555223 -
Association of Abdominal Myosteatosis and Visceral Fat Obesity with Arterial Stiffness.
- Lee MJ, Kim HK, Kim EH, Bae SJ, Nam HJ, Lee SH, Jung CH, Lee WJ.
- Endocrinol Metab (Seoul). 2026 Apr 8;41(4):543-557. doi: 10.3803/EnM.2025.2734.
- PMCID: PMC13555221
Lee MJ, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555221 -
Decline in Years of Life Lost Due to Diabetes in Korea, 2008-2019: A Cause-Specific Decomposition Analysis.
- Seo DH, Ha KH, Kim DJ.
- Endocrinol Metab (Seoul). 2026 Jan 28;41(4):558-565. doi: 10.3803/EnM.2025.2622.
- PMCID: PMC13555222
Seo DH, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13555222 -
Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study.
- Qiu X, Huang L, Jiang H, Ren X, Tang M, Yan T, Xu L, Pei C, Hu L.
- Endocrinol Metab (Seoul). 2026 Mar 4;41(3):415-427. doi: 10.3803/EnM.2025.2524.
- PMCID: PMC13352115
Qiu X, et al.Endocrinol Metab (Seoul). 2026.PMCID: PMC13352115 -
Romosozumab and Cardiovascular Safety: Bridging the Gap between Clinical Trials and Real-World Evidence.
- Kim BJ.
- Endocrinol Metab (Seoul). 2026 Jun 26;41(3):390-392. doi: 10.3803/EnM.2026.3119.
- PMCID: PMC13341178
Kim BJ.Endocrinol Metab (Seoul). 2026.PMCID: PMC13341178